CLINICAL_TRIALS
trial_result
· 2024-04-12
Clinical Trial Update: Neoadjuvant PD-1 Blockade in Resectable Oral Squamous Cell Carcinoma [Phase 2]
Summary
Phase 2 clinical trial evaluating neoadjuvant PD-1 blockade in patients with resectable oral squamous cell carcinoma has completed, and results were posted on 2…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hospital of Stomatology, Wuhan University | Conditions: Oral Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2024-04-12